Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 11/2015

Content (12 Articles)

Review

Analogue peptides for the immunotherapy of human acute myeloid leukemia

Susanne Hofmann, Andrew Mead, Aleksandrs Malinovskis, Nicola R. Hardwick, Barbara-ann Guinn

Original Article

T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response

Christina Pfirschke, Christoffer Gebhardt, Inka Zörnig, Maria Pritsch, Stefan B. Eichmüller, Dirk Jäger, Alexander Enk, Philipp Beckhove

Original Article

Surgical trauma induces postoperative T-cell dysfunction in lung cancer patients through the programmed death-1 pathway

Pingbo Xu, Ping Zhang, Zhirong Sun, Yun Wang, Jiawei Chen, Changhong Miao

Original Article

Cytokine-enhanced maturation and migration to the lymph nodes of a human dying melanoma cell-loaded dendritic cell vaccine

Gabriela A. Pizzurro, Ivana J. Tapia, Leonardo Sganga, Osvaldo L. Podhajcer, José Mordoh, María M. Barrio

Original Article

Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma

Hideyuki Takahashi, Koichi Sakakura, Reika Kawabata-Iwakawa, Susumu Rokudai, Minoru Toyoda, Masahiko Nishiyama, Kazuaki Chikamatsu

Open Access Original Article

Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen

Jurjen M. Ruben, Hetty J. Bontkes, Theresia M. Westers, Erik Hooijberg, Gert J. Ossenkoppele, Tanja D. de Gruijl, Arjan A. van de Loosdrecht

Original Article

The impact of leukapheresis on immune-cell number and function in patients with advanced cancer

James L. Gulley, Jennifer Marté, Christopher R. Heery, Ravi A. Madan, Seth M. Steinberg, Susan F. Leitman, Kwong Y. Tsang, Jeffrey Schlom

Original Article

Gene expression patterns in CD4+ peripheral blood cells in healthy subjects and stage IV melanoma patients

Sara J. Felts, Virginia P. Van Keulen, Adam D. Scheid, Kathleen S. Allen, Renee K. Bradshaw, Jin Jen, Tobias Peikert, Sumit Middha, Yuji Zhang, Matthew S. Block, Svetomir N. Markovic, Larry R. Pease

Original Article

Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment

Jaime F. Modiano, Beth A. Lindborg, Ron T. McElmurry, Mitzi Lewellen, Colleen L. Forster, Edward A. Zamora, Jerome Schaack, Donald Bellgrau, Timothy D. O’Brien, Jakub Tolar

Open Access Original Article

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets

Annette E. Sköld, Jasper J. P. van Beek, Simone P. Sittig, Ghaith Bakdash, Jurjen Tel, Gerty Schreibelt, I. Jolanda M. de Vries

Original Article

Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients

Fan Yan, Ruijuan Du, Feng Wei, Hua Zhao, Jinpu Yu, Changli Wang, Zhongli Zhan, Tingting Ding, Xiubao Ren, Xin Chen, Hui Li

Original Article

Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression

Alberto Sada Japp, M. Alper Kursunel, Sarah Meier, Julia N. Mälzer, Xiangdong Li, Nafis A. Rahman, Waltraut Jekabsons, Hans Krause, Ahmed Magheli, Christian Klopf, Andreas Thiel, Marco Frentsch

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine